ARTICLE | Clinical News

Viread tenofovir disoproxil fumarate: Additional Phase III data

November 9, 2009 8:00 AM UTC

Additional data from an open-label extension of the Phase III Study 103 in 266 patients with HBeAg-positive HBV showed that 72% of patients originally randomized to receive Viread had a virologic resp...